Found 22 matching trials
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
PHASE2The primary objective of this study is to evaluate the safety and efficacy ...
Location
UCI Center for Clinical Research
BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.
PHASE3Multicenter randomized double blind study versus placebo during 12 weeks wi...
Location
Centre Hospitalier Universitaire de Grenoble
Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)
PHASE3This is a multicentric international phase III, double blind randomized stu...
A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment
PHASE2* The study primary end point is the decrease in the number of monthly heav...
Location
Multiple Locations
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents
PHASE2Proof of concept, multicenter, randomized, double-blind, placebo-controlled...
Status
Active Not Recruiting
Location
Centre Hospitalier Charles Perrens
A Study of Pitolisant in Patients With Prader-Willi Syndrome
PHASE3This is a Phase 3, randomized, double-blind, placebo-controlled, multicente...
Location
Santa Monica Clinical Trials
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
PHASE3This is a Phase 3, multicenter, randomized, double-blind, parallel-group, p...
Location
Sleep Disorders Center of Alabama
A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
PHASE3The primary objective of this study is to evaluate the safety and efficacy ...
Location
Phoenix Medical Group
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
PHASE2The primary objective of this study is to evaluate the safety and efficacy ...
Location
Rady Children's Hospital - San Diego
Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
PHASE3To compare the efficacy of BF2.649 over placebo (12 week Double-Blind Phase...
Location
Klinik für Neurologie Universitätsklinikum